Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 78 | 2024 | 3752 | 9.850 |
Why?
|
Antirheumatic Agents | 19 | 2024 | 1365 | 3.680 |
Why?
|
Electronic Health Records | 44 | 2024 | 4803 | 3.010 |
Why?
|
Natural Language Processing | 17 | 2023 | 1163 | 2.910 |
Why?
|
International Classification of Diseases | 8 | 2020 | 909 | 1.770 |
Why?
|
Inflammatory Bowel Diseases | 12 | 2019 | 2423 | 1.570 |
Why?
|
Biological Products | 6 | 2024 | 912 | 1.550 |
Why?
|
Coronary Circulation | 7 | 2024 | 1569 | 1.500 |
Why?
|
Cardiovascular Diseases | 28 | 2024 | 15498 | 1.500 |
Why?
|
Peptides, Cyclic | 9 | 2017 | 392 | 1.440 |
Why?
|
Algorithms | 34 | 2024 | 14018 | 1.370 |
Why?
|
Troponin T | 3 | 2024 | 780 | 1.340 |
Why?
|
Rheumatology | 6 | 2024 | 615 | 1.220 |
Why?
|
Chondrocalcinosis | 2 | 2021 | 84 | 1.220 |
Why?
|
Microcirculation | 3 | 2024 | 1272 | 1.210 |
Why?
|
C-Reactive Protein | 7 | 2024 | 3822 | 1.190 |
Why?
|
Cholesterol, LDL | 8 | 2021 | 2379 | 1.150 |
Why?
|
Colitis, Ulcerative | 8 | 2019 | 1921 | 1.110 |
Why?
|
Autoantibodies | 12 | 2018 | 2115 | 1.110 |
Why?
|
Crohn Disease | 8 | 2019 | 2279 | 1.070 |
Why?
|
Lipids | 6 | 2024 | 3332 | 1.060 |
Why?
|
Phenotype | 22 | 2024 | 16571 | 1.020 |
Why?
|
Methotrexate | 6 | 2024 | 1716 | 0.960 |
Why?
|
Coronary Artery Disease | 12 | 2024 | 6403 | 0.920 |
Why?
|
Rheumatoid Factor | 6 | 2024 | 184 | 0.920 |
Why?
|
Inflammation | 12 | 2024 | 10760 | 0.860 |
Why?
|
Spondylarthritis | 2 | 2020 | 61 | 0.810 |
Why?
|
Rheumatic Diseases | 3 | 2024 | 649 | 0.790 |
Why?
|
Sjogren's Syndrome | 2 | 2014 | 237 | 0.780 |
Why?
|
Spondylitis, Ankylosing | 2 | 2020 | 155 | 0.780 |
Why?
|
Lipoproteins, HDL | 2 | 2017 | 675 | 0.750 |
Why?
|
Coronary Vessels | 5 | 2024 | 3095 | 0.750 |
Why?
|
Drug Substitution | 1 | 2024 | 290 | 0.750 |
Why?
|
Information Storage and Retrieval | 4 | 2019 | 819 | 0.730 |
Why?
|
Hydroxychloroquine | 2 | 2024 | 426 | 0.720 |
Why?
|
Hyperlipidemias | 4 | 2018 | 770 | 0.710 |
Why?
|
Veterans | 4 | 2024 | 2649 | 0.680 |
Why?
|
Polymorphism, Single Nucleotide | 16 | 2024 | 15908 | 0.630 |
Why?
|
Genetic Association Studies | 5 | 2024 | 2734 | 0.620 |
Why?
|
Dyslipidemias | 3 | 2015 | 868 | 0.620 |
Why?
|
Humans | 151 | 2024 | 760617 | 0.620 |
Why?
|
Data Mining | 2 | 2021 | 551 | 0.620 |
Why?
|
Genetic Predisposition to Disease | 17 | 2024 | 17878 | 0.610 |
Why?
|
Calcium Pyrophosphate | 1 | 2018 | 55 | 0.600 |
Why?
|
Vitamin D | 5 | 2015 | 3302 | 0.590 |
Why?
|
Myocardial Ischemia | 3 | 2023 | 2110 | 0.560 |
Why?
|
Middle Aged | 66 | 2024 | 220584 | 0.560 |
Why?
|
Gastrointestinal Agents | 3 | 2018 | 510 | 0.550 |
Why?
|
Lupus Erythematosus, Systemic | 4 | 2021 | 2152 | 0.540 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2022 | 4341 | 0.540 |
Why?
|
Arthrography | 2 | 2014 | 150 | 0.530 |
Why?
|
Gout | 1 | 2023 | 621 | 0.530 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2112 | 0.520 |
Why?
|
Interleukin-1 | 2 | 2023 | 1248 | 0.520 |
Why?
|
Receptors, Interleukin-6 | 3 | 2024 | 224 | 0.520 |
Why?
|
Male | 78 | 2024 | 360358 | 0.500 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2021 | 1723 | 0.490 |
Why?
|
Risk Factors | 39 | 2024 | 74115 | 0.490 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5835 | 0.480 |
Why?
|
Fibrinogen | 1 | 2018 | 887 | 0.470 |
Why?
|
Female | 80 | 2024 | 392148 | 0.470 |
Why?
|
Drug Therapy, Combination | 2 | 2024 | 6305 | 0.470 |
Why?
|
Lipoproteins, LDL | 2 | 2019 | 642 | 0.470 |
Why?
|
Arthralgia | 1 | 2018 | 461 | 0.460 |
Why?
|
Blood Sedimentation | 2 | 2019 | 235 | 0.460 |
Why?
|
Aged | 47 | 2024 | 169042 | 0.450 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 933 | 0.450 |
Why?
|
Vitamin D Deficiency | 2 | 2013 | 1388 | 0.440 |
Why?
|
Genome-Wide Association Study | 11 | 2024 | 12661 | 0.440 |
Why?
|
Risk Assessment | 11 | 2022 | 23972 | 0.430 |
Why?
|
Hospitalization | 7 | 2022 | 10704 | 0.430 |
Why?
|
Joints | 1 | 2014 | 322 | 0.420 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 299 | 0.420 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2024 | 575 | 0.400 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 177 | 0.390 |
Why?
|
Cohort Studies | 22 | 2022 | 41457 | 0.380 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2723 | 0.380 |
Why?
|
Antibodies, Antinuclear | 1 | 2013 | 342 | 0.380 |
Why?
|
Arteritis | 2 | 2024 | 158 | 0.380 |
Why?
|
Peptide Fragments | 2 | 2021 | 5110 | 0.370 |
Why?
|
Hand Joints | 1 | 2011 | 58 | 0.360 |
Why?
|
Parturition | 1 | 2014 | 447 | 0.360 |
Why?
|
Prognosis | 15 | 2022 | 29600 | 0.360 |
Why?
|
Epitopes | 1 | 2017 | 2501 | 0.360 |
Why?
|
Vasodilation | 1 | 2014 | 962 | 0.350 |
Why?
|
Immunologic Factors | 3 | 2022 | 1589 | 0.340 |
Why?
|
Depressive Disorder | 2 | 2013 | 3735 | 0.340 |
Why?
|
Adult | 47 | 2024 | 220969 | 0.340 |
Why?
|
Cholesterol, HDL | 2 | 2019 | 1810 | 0.340 |
Why?
|
Anterior Compartment Syndrome | 1 | 2008 | 8 | 0.320 |
Why?
|
Lipoproteins | 1 | 2013 | 879 | 0.320 |
Why?
|
Apolipoprotein A-I | 3 | 2021 | 299 | 0.320 |
Why?
|
Apolipoproteins B | 3 | 2021 | 385 | 0.310 |
Why?
|
Myocardium | 1 | 2021 | 4724 | 0.300 |
Why?
|
Area Under Curve | 4 | 2020 | 1635 | 0.300 |
Why?
|
Heart Diseases | 1 | 2021 | 2778 | 0.300 |
Why?
|
Hypothyroidism | 1 | 2013 | 667 | 0.300 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2574 | 0.300 |
Why?
|
Early Diagnosis | 2 | 2009 | 1185 | 0.290 |
Why?
|
Thromboembolism | 1 | 2014 | 991 | 0.290 |
Why?
|
Quality Improvement | 2 | 2020 | 3797 | 0.290 |
Why?
|
Delivery, Obstetric | 1 | 2014 | 939 | 0.280 |
Why?
|
Atherosclerosis | 1 | 2023 | 3400 | 0.280 |
Why?
|
Clostridium Infections | 1 | 2014 | 557 | 0.280 |
Why?
|
Semantics | 2 | 2022 | 612 | 0.270 |
Why?
|
Disease Progression | 6 | 2021 | 13495 | 0.270 |
Why?
|
Colonoscopy | 1 | 2014 | 1396 | 0.260 |
Why?
|
Cholesterol | 4 | 2021 | 2903 | 0.260 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2021 | 64 | 0.260 |
Why?
|
Sulfasalazine | 2 | 2024 | 84 | 0.260 |
Why?
|
Colorectal Neoplasms | 3 | 2016 | 6925 | 0.260 |
Why?
|
Medical Informatics | 1 | 2013 | 732 | 0.260 |
Why?
|
Cesarean Section | 1 | 2014 | 1396 | 0.250 |
Why?
|
Antibodies | 2 | 2014 | 2414 | 0.250 |
Why?
|
HLA Antigens | 3 | 2023 | 1329 | 0.240 |
Why?
|
Follow-Up Studies | 13 | 2019 | 39063 | 0.240 |
Why?
|
Incidence | 13 | 2024 | 21337 | 0.220 |
Why?
|
Synovial Membrane | 2 | 2024 | 532 | 0.220 |
Why?
|
Inflammation Mediators | 3 | 2024 | 1884 | 0.220 |
Why?
|
Blood Pressure | 2 | 2018 | 8472 | 0.220 |
Why?
|
Genotype | 8 | 2023 | 12978 | 0.210 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2024 | 324 | 0.210 |
Why?
|
Cleft Palate | 1 | 2008 | 589 | 0.210 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 36 | 0.210 |
Why?
|
Psoriasis | 2 | 2021 | 944 | 0.200 |
Why?
|
Sigmoid Neoplasms | 1 | 2022 | 53 | 0.200 |
Why?
|
Interleukin-6 | 2 | 2023 | 3206 | 0.200 |
Why?
|
Janus Kinases | 1 | 2023 | 248 | 0.200 |
Why?
|
Unified Medical Language System | 2 | 2019 | 89 | 0.200 |
Why?
|
Alleles | 7 | 2023 | 6861 | 0.200 |
Why?
|
Sickle Cell Trait | 1 | 2022 | 85 | 0.190 |
Why?
|
Logistic Models | 7 | 2019 | 13245 | 0.190 |
Why?
|
Heart Failure | 2 | 2022 | 11669 | 0.190 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 12142 | 0.190 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 14648 | 0.180 |
Why?
|
Registries | 4 | 2022 | 8207 | 0.180 |
Why?
|
Triglycerides | 2 | 2021 | 2459 | 0.180 |
Why?
|
Risk | 4 | 2018 | 9604 | 0.180 |
Why?
|
Case-Control Studies | 13 | 2021 | 22148 | 0.180 |
Why?
|
Lipid Metabolism | 2 | 2019 | 1896 | 0.170 |
Why?
|
Medical Record Linkage | 1 | 2021 | 286 | 0.170 |
Why?
|
Vasculitis | 1 | 2024 | 522 | 0.170 |
Why?
|
Societies, Medical | 2 | 2011 | 3900 | 0.170 |
Why?
|
Comorbidity | 6 | 2023 | 10505 | 0.170 |
Why?
|
Incidental Findings | 1 | 2024 | 697 | 0.170 |
Why?
|
Myeloblastin | 1 | 2019 | 101 | 0.160 |
Why?
|
Veterans Health | 1 | 2021 | 215 | 0.160 |
Why?
|
United States Department of Veterans Affairs | 1 | 2024 | 928 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2016 | 12043 | 0.160 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2021 | 344 | 0.160 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1434 | 0.160 |
Why?
|
Validation Studies as Topic | 1 | 2019 | 162 | 0.160 |
Why?
|
Vital Signs | 1 | 2019 | 144 | 0.150 |
Why?
|
Anticoagulants | 1 | 2014 | 4785 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2024 | 998 | 0.150 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14591 | 0.150 |
Why?
|
Pain, Postoperative | 1 | 2008 | 1737 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 587 | 0.150 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2689 | 0.150 |
Why?
|
United States | 16 | 2024 | 72272 | 0.150 |
Why?
|
Research Design | 4 | 2024 | 6174 | 0.150 |
Why?
|
Proportional Hazards Models | 6 | 2022 | 12447 | 0.140 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2019 | 289 | 0.140 |
Why?
|
Musculoskeletal Diseases | 1 | 2023 | 597 | 0.140 |
Why?
|
Stroke Volume | 2 | 2022 | 5486 | 0.140 |
Why?
|
Snow | 1 | 2017 | 15 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 515 | 0.140 |
Why?
|
Peroxidase | 1 | 2019 | 610 | 0.130 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2019 | 225 | 0.130 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2024 | 2008 | 0.130 |
Why?
|
Prospective Studies | 6 | 2023 | 54360 | 0.130 |
Why?
|
Likelihood Functions | 1 | 2019 | 991 | 0.130 |
Why?
|
Genetic Variation | 3 | 2024 | 6561 | 0.130 |
Why?
|
TYK2 Kinase | 1 | 2015 | 38 | 0.120 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2023 | 940 | 0.120 |
Why?
|
Retrospective Studies | 13 | 2022 | 80566 | 0.120 |
Why?
|
Boston | 4 | 2017 | 9313 | 0.120 |
Why?
|
Medical Informatics Applications | 1 | 2016 | 179 | 0.120 |
Why?
|
Neoplasms | 2 | 2014 | 22131 | 0.120 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15828 | 0.120 |
Why?
|
Skin Diseases | 1 | 2023 | 1094 | 0.120 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 3415 | 0.110 |
Why?
|
Rectal Fistula | 1 | 2014 | 75 | 0.110 |
Why?
|
Creatinine | 1 | 2019 | 1896 | 0.110 |
Why?
|
Lymphoma | 1 | 2023 | 1899 | 0.110 |
Why?
|
Genetic Pleiotropy | 1 | 2015 | 181 | 0.110 |
Why?
|
Aortic Aneurysm | 1 | 2018 | 648 | 0.110 |
Why?
|
Scleroderma, Systemic | 1 | 2017 | 344 | 0.110 |
Why?
|
Probability | 1 | 2018 | 2475 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2447 | 0.110 |
Why?
|
Pleurisy | 1 | 2013 | 54 | 0.100 |
Why?
|
Biometry | 1 | 2016 | 561 | 0.100 |
Why?
|
Thyroiditis | 1 | 2013 | 86 | 0.100 |
Why?
|
Multiple Sclerosis | 2 | 2021 | 3222 | 0.100 |
Why?
|
Aged, 80 and over | 8 | 2021 | 58894 | 0.100 |
Why?
|
Positron-Emission Tomography | 3 | 2024 | 6483 | 0.100 |
Why?
|
Treatment Outcome | 5 | 2024 | 64568 | 0.100 |
Why?
|
Propensity Score | 1 | 2019 | 1911 | 0.100 |
Why?
|
B-Lymphocytes | 2 | 2023 | 4745 | 0.100 |
Why?
|
Transglutaminases | 1 | 2013 | 196 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 26049 | 0.100 |
Why?
|
Primary Prevention | 1 | 2019 | 1185 | 0.100 |
Why?
|
Prevalence | 3 | 2021 | 15689 | 0.100 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 397 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2019 | 1389 | 0.090 |
Why?
|
Iodide Peroxidase | 1 | 2013 | 294 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3410 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2023 | 2533 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2016 | 3244 | 0.090 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 506 | 0.090 |
Why?
|
Nutrition Surveys | 1 | 2018 | 1723 | 0.090 |
Why?
|
Managed Care Programs | 1 | 2016 | 937 | 0.090 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 418 | 0.090 |
Why?
|
Laparoscopy | 1 | 2022 | 2030 | 0.090 |
Why?
|
Postoperative Complications | 1 | 2013 | 15612 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3683 | 0.090 |
Why?
|
Peripheral Arterial Disease | 1 | 2021 | 1271 | 0.090 |
Why?
|
Medicare | 3 | 2023 | 6765 | 0.090 |
Why?
|
Sweden | 2 | 2013 | 1379 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1924 | 0.090 |
Why?
|
Time Factors | 4 | 2018 | 39913 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2012 | 638 | 0.080 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2014 | 709 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 928 | 0.080 |
Why?
|
Digestive System Surgical Procedures | 1 | 2014 | 571 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13382 | 0.080 |
Why?
|
Young Adult | 11 | 2022 | 59179 | 0.080 |
Why?
|
Research | 2 | 2023 | 1977 | 0.080 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 949 | 0.080 |
Why?
|
Gene Frequency | 2 | 2012 | 3601 | 0.080 |
Why?
|
Linear Models | 2 | 2018 | 5866 | 0.080 |
Why?
|
ROC Curve | 4 | 2024 | 3575 | 0.080 |
Why?
|
Chronic Disease | 2 | 2021 | 9311 | 0.080 |
Why?
|
Inpatients | 1 | 2019 | 2544 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11459 | 0.070 |
Why?
|
Odds Ratio | 3 | 2015 | 9643 | 0.070 |
Why?
|
Adolescent | 11 | 2017 | 88234 | 0.070 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 872 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3607 | 0.070 |
Why?
|
Models, Statistical | 3 | 2017 | 5073 | 0.070 |
Why?
|
Autoimmunity | 1 | 2015 | 1350 | 0.070 |
Why?
|
Contraceptives, Oral | 1 | 2009 | 553 | 0.070 |
Why?
|
Azathioprine | 2 | 2019 | 354 | 0.070 |
Why?
|
Genetic Loci | 2 | 2015 | 2624 | 0.070 |
Why?
|
Disease Management | 2 | 2015 | 2506 | 0.070 |
Why?
|
Smith-Lemli-Opitz Syndrome | 1 | 2006 | 46 | 0.070 |
Why?
|
Stroke | 2 | 2021 | 9712 | 0.070 |
Why?
|
Meat | 1 | 2009 | 584 | 0.070 |
Why?
|
Smoking | 3 | 2013 | 9050 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2017 | 2985 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2015 | 2188 | 0.060 |
Why?
|
Drug Discovery | 1 | 2013 | 1051 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4174 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3533 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1418 | 0.060 |
Why?
|
Cell Degranulation | 1 | 2006 | 277 | 0.060 |
Why?
|
Dyspnea | 1 | 2013 | 1347 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6338 | 0.060 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2006 | 174 | 0.060 |
Why?
|
Hypertension | 2 | 2016 | 8529 | 0.060 |
Why?
|
Models, Genetic | 1 | 2014 | 3431 | 0.060 |
Why?
|
Sex Factors | 2 | 2021 | 10548 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6474 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5031 | 0.060 |
Why?
|
Knowledge Bases | 1 | 2024 | 97 | 0.060 |
Why?
|
Leg | 1 | 2008 | 1087 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2018 | 3954 | 0.050 |
Why?
|
Informatics | 1 | 2023 | 71 | 0.050 |
Why?
|
Logical Observation Identifiers Names and Codes | 1 | 2022 | 16 | 0.050 |
Why?
|
Lung Diseases | 1 | 2013 | 1909 | 0.050 |
Why?
|
Computer Simulation | 4 | 2019 | 6233 | 0.050 |
Why?
|
Whole Body Imaging | 1 | 2024 | 283 | 0.050 |
Why?
|
Cluster Analysis | 2 | 2019 | 2700 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2812 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3194 | 0.050 |
Why?
|
Cyclophosphamide | 2 | 2019 | 2218 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
Sample Size | 2 | 2016 | 838 | 0.050 |
Why?
|
Computational Biology | 3 | 2024 | 3509 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2016 | 4321 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2009 | 2697 | 0.050 |
Why?
|
Massachusetts | 1 | 2014 | 8833 | 0.050 |
Why?
|
Birth Weight | 1 | 2009 | 2101 | 0.050 |
Why?
|
Breast Feeding | 1 | 2009 | 1354 | 0.050 |
Why?
|
Calibration | 1 | 2023 | 817 | 0.040 |
Why?
|
Alcohol Drinking | 2 | 2013 | 4025 | 0.040 |
Why?
|
Patient Readmission | 1 | 2014 | 3269 | 0.040 |
Why?
|
Social Class | 1 | 2009 | 1992 | 0.040 |
Why?
|
Survival Rate | 1 | 2014 | 12719 | 0.040 |
Why?
|
Research Personnel | 1 | 2024 | 588 | 0.040 |
Why?
|
Health Surveys | 1 | 2009 | 4037 | 0.040 |
Why?
|
Mast Cells | 1 | 2006 | 1392 | 0.040 |
Why?
|
Disclosure | 1 | 2024 | 747 | 0.040 |
Why?
|
Osteoarthritis | 2 | 2016 | 1063 | 0.040 |
Why?
|
Pregnancy | 3 | 2015 | 29868 | 0.040 |
Why?
|
Biological Assay | 1 | 2021 | 626 | 0.040 |
Why?
|
Exons | 2 | 2015 | 2381 | 0.040 |
Why?
|
Current Procedural Terminology | 1 | 2018 | 89 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9461 | 0.040 |
Why?
|
Europe | 2 | 2017 | 3413 | 0.040 |
Why?
|
Automation | 1 | 2019 | 585 | 0.030 |
Why?
|
Colectomy | 1 | 2022 | 686 | 0.030 |
Why?
|
Documentation | 1 | 2023 | 895 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2006 | 1167 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2238 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2021 | 973 | 0.030 |
Why?
|
Age Factors | 3 | 2021 | 18381 | 0.030 |
Why?
|
Penicillamine | 1 | 2016 | 60 | 0.030 |
Why?
|
Hemoglobins | 1 | 2022 | 1524 | 0.030 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 2016 | 0.030 |
Why?
|
Pattern Recognition, Automated | 1 | 2022 | 994 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 786 | 0.030 |
Why?
|
Minocycline | 1 | 2016 | 169 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2650 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7960 | 0.030 |
Why?
|
Confidentiality | 1 | 2019 | 608 | 0.030 |
Why?
|
Lung | 1 | 2013 | 9998 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2009 | 4483 | 0.030 |
Why?
|
Mass Screening | 1 | 2009 | 5424 | 0.030 |
Why?
|
Genetic Research | 1 | 2014 | 171 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12966 | 0.030 |
Why?
|
Cold Temperature | 1 | 2017 | 784 | 0.030 |
Why?
|
Medical Audit | 1 | 2014 | 453 | 0.030 |
Why?
|
Japan | 1 | 2017 | 1372 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2012 | 14 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2021 | 2570 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2022 | 4242 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 2895 | 0.020 |
Why?
|
Outpatients | 1 | 2020 | 1596 | 0.020 |
Why?
|
Republic of Korea | 1 | 2014 | 583 | 0.020 |
Why?
|
Drug Repositioning | 1 | 2013 | 233 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 609 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2023 | 4470 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2326 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3879 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 750 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1650 | 0.020 |
Why?
|
Acute-Phase Reaction | 1 | 2010 | 91 | 0.020 |
Why?
|
Survival Analysis | 1 | 2023 | 10073 | 0.020 |
Why?
|
Ikaros Transcription Factor | 1 | 2012 | 232 | 0.020 |
Why?
|
Clinical Chemistry Tests | 1 | 2010 | 59 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 12933 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 564 | 0.020 |
Why?
|
Parity | 1 | 2013 | 924 | 0.020 |
Why?
|
Heart | 1 | 2023 | 4403 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20074 | 0.020 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2010 | 146 | 0.020 |
Why?
|
Drug Utilization | 1 | 2015 | 1186 | 0.020 |
Why?
|
Hospital Information Systems | 1 | 2012 | 394 | 0.020 |
Why?
|
Proteins | 1 | 2024 | 6030 | 0.020 |
Why?
|
Neprilysin | 1 | 2012 | 478 | 0.020 |
Why?
|
Synovitis | 1 | 2010 | 217 | 0.020 |
Why?
|
Accidental Falls | 1 | 2017 | 1065 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1602 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2426 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7373 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8426 | 0.020 |
Why?
|
Health | 1 | 2011 | 398 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1683 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5061 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3742 | 0.020 |
Why?
|
Calcium | 1 | 2020 | 5717 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1994 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7045 | 0.020 |
Why?
|
North America | 1 | 2010 | 1273 | 0.020 |
Why?
|
Dehydrocholesterols | 1 | 2006 | 20 | 0.020 |
Why?
|
Syndrome | 1 | 2013 | 3268 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1810 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2006 | 129 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10175 | 0.020 |
Why?
|
Peptides | 1 | 2018 | 4354 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2509 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2013 | 14389 | 0.020 |
Why?
|
Membrane Microdomains | 1 | 2006 | 206 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15251 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3302 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2491 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1421 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2006 | 535 | 0.010 |
Why?
|
Body Mass Index | 1 | 2021 | 12943 | 0.010 |
Why?
|
Medicaid | 1 | 2016 | 2814 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2010 | 1528 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 3085 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10199 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2012 | 7847 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1896 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6961 | 0.010 |
Why?
|
Nurses | 1 | 2011 | 2477 | 0.010 |
Why?
|
Consensus | 1 | 2010 | 3117 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2010 | 1998 | 0.010 |
Why?
|
Protein Transport | 1 | 2006 | 1966 | 0.010 |
Why?
|
Software | 1 | 2014 | 4431 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9172 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42188 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3680 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 1971 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20556 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2006 | 2446 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8311 | 0.010 |
Why?
|
Mice | 2 | 2013 | 81368 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2006 | 18937 | 0.010 |
Why?
|
Animals | 2 | 2013 | 168201 | 0.000 |
Why?
|
Child | 1 | 2015 | 80079 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18221 | 0.000 |
Why?
|